Analyst Ratings for Arrowhead Pharma (ARWR)
ARWR Rating Summary
ARWR Price Target Summary
- Highest: $110.00 (Piper Sandler)
- Lowest: $21.00 (Leerink Partners)
- Average: $77.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$77.11 (+28.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2024 | Goldman Sachs » Updated 2/9/2026 |
Andrea Tan | New Coverage | Neutral (N/A) |
85.00 (N/A) |
24.62 (59.82) |
142.97% | Details |
| 12/4/2023 | BofA Securities » Updated 1/7/2026 |
Jason Gerberry | New Coverage | Buy (N/A) |
84.00 (81.00) |
23.17 (59.82) |
158.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
